Health
Pfizer and BioNTech coronavirus vaccine accepted for rolling review in Canada – Motley Fool Australia
Health Canada will determine BNT162b2’s suitability for approval as clinical trial data comes in.
This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.
The coronavirus vaccine candidate being developed by Pfizer(NYSE: PFE) and BioNTech(NASDAQ: BNTX) is now undergoing its first regulatory review in North America. The two companies announced that their BNT162b2 has been accepted for a rolling review by Health Canada, that country’s healthcare regulatory authority.
A rolling review is one undertaken while a candidate is still in developme…
-
General24 hours agoQueensland government expands youth justice laws, David Crisafulli tells UN critics ‘you don’t control me’
-
General23 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
General15 hours agoThree maps that show the scale of the NSW flood disaster
-
Business23 hours agoWhere could the RBA interest rate go in the next 12 months?